Projects per year
Organization profile
Organization profile
The Center for Drug Design (CDD) is a distinctive, cutting edge research facility in the Academic Health Center of the University of Minnesota. We are dedicated to: Providing a research environment for leading scientists, Sharing unique strategies within the scientific community, Developing novel drug therapies, Vigorously pursuing an academic research agenda, Transferring scientific knowledge, Designing and developing new medicines to benefit people worldwide, Supporting the interaction of many disciplines and areas of study, and Creating a focal point for research.
Fingerprint Dive into the research topics where Center for Drug Design is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Nucleosides
Medicine & Life Sciences
carbovir
Medicine & Life Sciences
Antiviral Agents
Medicine & Life Sciences
Organophosphonates
Medicine & Life Sciences
NAD
Medicine & Life Sciences
Inosine Monophosphate
Medicine & Life Sciences
HIV Reverse Transcriptase
Medicine & Life Sciences
Puromycin
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 2005 2023
Nematicides and Seed Treatments for Control of SCN and SDS
Bushley, K. E., Chen, S. & Salomon, C.
MN SOYBEAN RESEARCH & PROMOTION COUNCIL
5/1/19 → 4/30/20
Project: Research project
nematicides
seed treatment
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein
Geraghty, R. J., Aihara, H., Wang, Z. & Xie, J.
NIH Nat'l Inst of Allergy & Infect Dis
1/25/19 → 12/31/23
Project: Research project
Proteins
terminase
Retinal Changes in Alzheimer's Disease (AD) and Cerebral Amyloid Staging Correlations, A Promising Early Biomarker in AD
More, S. S., Bell, W. R. & Flanagan, M. E.
Winston & Maxine Wallin Neuro Disc Fund
1/1/19 → 12/31/19
Project: Research project
Amyloid
Alzheimer Disease
Biomarkers
Research Output 1965 2019
1
Citation
(Scopus)
5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors
TANG, JING., Huber, A. D., Pineda, D. L., Boschert, K. N., Wolf, J. J., Kankanala, J., Xie, J., Sarafianos, S. G. & Wang, Z., Feb 15 2019, In : European Journal of Medicinal Chemistry. 164, p. 179-192 14 p.Research output: Contribution to journal › Article
Virus Assembly
Capsid
Viruses
Hepatitis B virus
Viral Core Proteins
Challenges and Opportunities in Hepatitis B Research
Wang, Z., May 10 2019, In : ACS Infectious Diseases. 5, 5, p. 652-654 3 p.Research output: Contribution to journal › Editorial
Hepatitis B
Research
Discovery of Irreversible p97 Inhibitors
Ding, R., Zhang, T., Wilson, D., Xie, J., Williams, J., Xu, Y., Ye, Y. & Chen, L., Mar 14 2019, In : Journal of Medicinal Chemistry. 62, 5, p. 2814-2829 16 p.Research output: Contribution to journal › Article
Amides
Mutagenesis
Cysteine
Mass Spectrometry
Neoplasms